期刊论文详细信息
Marine Drugs
Molecular Mechanisms by Which a Fucus vesiculosus Extract Mediates Cell Cycle Inhibition and Cell Death in Pancreatic Cancer Cells
Ulf Geisen1  Marion Zenthoefer5  Matthias Peipp6  Jannik Kerber1  Johannes Plenge4  Antonella Managò2  Markus Fuhrmann3  Roland Geyer3  Steffen Hennig5  Dieter Adam4  Levent Piker5  Gerald Rimbach7  Holger Kalthoff1 
[1] Division of Molecular Oncology, Institute for Experimental Cancer Research, Medical Faculty, CAU, University Hospital Schleswig-Holstein, 24105 Kiel, Germany; E-Mails:;Department of Biology, University of Padua, 35131 Padua, Italy; E-Mail:;Numares AG, 93053 Regensburg, Germany; E-Mails:;Institute of Immunology, University Hospital Schleswig-Holstein, 24105 Kiel, Germany; E-Mails:;CRM, Coastal Research & Management, 24159 Kiel, Germany; E-Mails:;Division of Stem Cell Transplantation and Immunotherapy, Department of Internal Medicine II, University Hospital Schleswig-Holstein, 24105 Kiel, Germany; E-Mail:;Institute of Human Nutrition and Food Science, Christian-Albrechts University of Kiel, 24118 Kiel, Germany; E-Mail:
关键词: algae;    Fucus vesiculosus;    pancreatic;    cancer;    cell cycle inhibitors;    autophagy;    proliferation;   
DOI  :  10.3390/md13074470
来源: mdpi
PDF
【 摘 要 】

Pancreatic cancer is one of the most aggressive cancer entities, with an extremely poor 5-year survival rate. Therefore, novel therapeutic agents with specific modes of action are urgently needed. Marine organisms represent a promising source to identify new pharmacologically active substances. Secondary metabolites derived from marine algae are of particular interest. The present work describes cellular and molecular mechanisms induced by an HPLC-fractionated, hydrophilic extract derived from the Baltic brown seaweed Fucus vesiculosus (Fv1). Treatment with Fv1 resulted in a strong inhibition of viability in various pancreatic cancer cell lines. This extract inhibited the cell cycle of proliferating cells due to the up-regulation of cell cycle inhibitors, shown on the mRNA (microarray data) and protein level. As a result, cells were dying in a caspase-independent manner. Experiments with non-dividing cells showed that proliferation is a prerequisite for the effectiveness of Fv1. Importantly, Fv1 showed low cytotoxic activity against non-malignant resting T cells and terminally differentiated cells like erythrocytes. Interestingly, accelerated killing effects were observed in combination with inhibitors of autophagy. Our in vitro data suggest that Fv1 may represent a promising new agent that deserves further development towards clinical application.

【 授权许可】

CC BY   
© 2015 by the authors; licensee MDPI, Basel, Switzerland.

【 预 览 】
附件列表
Files Size Format View
RO202003190009484ZK.pdf 3733KB PDF download
  文献评价指标  
  下载次数:13次 浏览次数:18次